Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Net Income towards Common Stockholders (2020 - 2025)

HCW Biologics (HCWB) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$4.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 16.54% year-over-year to -$4.6 million, compared with a TTM value of -$13.9 million through Sep 2025, up 63.02%, and an annual FY2024 reading of -$30.1 million, down 15.81% over the prior year.
  • Net Income towards Common Stockholders was -$4.6 million for Q3 2025 at HCW Biologics, down from -$3.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$2.1 million in Q1 2022 and bottomed at -$15.3 million in Q2 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$5.0 million, with a median of -$4.1 million recorded in 2022.
  • The sharpest move saw Net Income towards Common Stockholders tumbled 235.66% in 2021, then skyrocketed 75.97% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$2.2 million in 2021, then plummeted by 160.31% to -$5.8 million in 2022, then plummeted by 86.87% to -$10.8 million in 2023, then surged by 68.4% to -$3.4 million in 2024, then plummeted by 33.85% to -$4.6 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for HCWB at -$4.6 million in Q3 2025, -$3.7 million in Q2 2025, and -$2.2 million in Q1 2025.